Revvity (RVTY) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · United States · ISIN US7140461093
Revvity financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.86 bn USD |
| Operating income | 356.64 m USD |
| EBIT | 330.68 m USD |
| Net income | 241.20 m USD |
| Diluted EPS – continuing operations | 2.07 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Revvity
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
More stocks
- Tractor Supply (TSCO)
- REINSURANCE GROUP OF AMERICA INC (RGA)
- Air China Ltd Class A (601111.SS)
- Hong Kong and China Gas Co Ltd (3.HK)
- Zhen Ding Technology Holding Ltd (4958.TW)
- KGHM Polska Miedz SA (KGH.WA)
- FTAI Aviation Ltd. (FTAI)
- Koninklijke KPN NV (KPN.AS)
- SEGRO PLC (SGRO.L)
- Kerry Group PLC (KRZ.IR)
- International Paper (IP)
- Whitecap Resources Inc (WCP.TO)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.